maximizing Oncology exploration with built-in KRAS Assay solutions and RAS Assays
from the promptly evolving industry of oncology investigation, accurate and effective mutation screening is vital for creating qualified therapies. The KRAS companies Platform performs a pivotal role Within this landscape by supplying thorough solutions for KRAS mutation profiling and Examination. KRAS mutations, found in approximately 95% of RAS-s